All eligible subjects signed university-approved informed consent documents and approval was granted by the Institutional Review Board for the Protection of Human Subjects of Baylor University and Research Ethical Review Committee of Kyowa Hakko Kirin Co., Ltd
(Mounjaro) 2025 (GIP/GLP-1) Tirzepatide GLP-1 GIP GLP-1 SURMOUNT-1 20.9% (HbA1c) 8-12 ( BMI kg/m) BMI kg/m () (MTC) (MEN 2) (Tirzepatide) 4 Mounjaro 24 72 Mounjaro Line / FAQ 10 Q1 (Mounjaro) AGIP GLP-1 Q2 A GLP-1 GIP Q3 A Q4 A Q5 A (BMI) Q6 A Q7 A Q8/ A Q9 A Q10 A InBody : LINE : @wholehealthclinic : | 976 : MON - FRI1O:3O 21:OO SAT1O:OO 19:OO
Product is not tested for safety and efficacy in food, drug, medical device, cosmetic, no express or implied authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, for humans or animals or for commercial purposes
In the NVU, BECs regulate ion transport through modulating TJ, receptors, and ion channel expression (130)
Baseline and ongoing labs (A1c, metabolic panel, lipids) to screen and monitor
